Why EximRx / Who we serve

Evidence to validate what you already know and uncover what you don’t.

Whether you sell into a market, invest in one or advise on it.

Who we serve

Three kinds of team, three kinds of question.

Pharma companies, distributors, traders and CDMOs

Find your next market. See where demand sits, who serves it today and how much of it you could win.

  • Size demand by molecule, ATC class and geography
  • Identify the suppliers you compete with, and the buyers they sell to
  • Find partners and distributors in new markets
Private equity and investors

Test the story. Check a target’s real trade footprint before you commit.

  • Verify export volumes, customers and geographies
  • Benchmark against competitors in the same molecules
  • Spot concentration risk in buyers or markets
Consulting firms and auditors

Market maps you can defend. Classified data, with the underlying records ready when a client or reviewer asks.

  • Build market sizing and competitive landscapes in hours, not weeks
  • Trace every number back to source shipments
  • Validate company-reported trade figures
How we serve

Where EximRx supports you.

Across the 53 markets we assessed, here is how much audited data exists, and what EximRx adds.

20

No audited data

Your primary view of the market: no audited data exists, so EximRx gives a reliable picture of existing demand in import-dependent markets.

21

Retail-only or limited coverage

Complete the picture: audited data covers only the retail channel or has limited coverage, so EximRx adds a fuller view of at least the imported segment.

12

Strong audit coverage

Validate and go deeper: EximRx works as an independent check that does not rely on extrapolation, and reaches categories audited data leaves out.

Explore market coverage →

Tell us the market, molecule or company you are looking at.

Talk to our teamExplore market coverage